에 대한 최신 뉴스 Nutrien (NYSE:NTR) 주식

Nutrien

Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients--nitrogen, potash, and phosphate--although its main focus is potash, where it is the global leader in installed capacity with a roughly 20% market share. The company is also the largest agricultural retailer in the United States, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.

News

Global

Movers

모자이크 컴퍼니(NYSE:MOS)와 뉴트리엔(NYSE:NTR)을 포함한 비료 주식은 벨라루스 대통령 알렉산더 루카셴코가 러시아 생산자들과 함께 칼륨 생산량 감축을 제안한 후 월요일 상승세를 보였다.

벨라루스 대통령의 칼륨 생산 감축 언급에 월요일 모자이크, 뉴트리엔 등 비료 주식 상승

CELH

MBLY

MSTR

ORAN

PARAA

PYPL

이들 10개 대형주는 지난 주 최악의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요? 셀시어스 홀딩스(NASDAQ:CELH)는 여러 분석가들이 주식 가격 예측을 낮추면서 지난주 15.22% 하락했다. 골드 필드(NYSE:GFI)의 주식은 살라레스 노르테(Salares Norte) 프로젝트에 대한 기상 현상의 영향으로 회사가 2024년 그룹 생산 지침을 낮추면서 12.59% 하락했다. 

셀시어스와 페이팔이 지난주 최악의 성과를 보인 10개의 대형주 중 일부 (6월 9일-6월 15일)

Nutrien Ltd

Natera Inc

Nutriband Inc

S&P/TSX Composite Index (USD Net TR)

S&P/TSX Composite ESG Tilted NTR (USD)

Global X Funds Carbon Cr Strategy ETF

Neutron - United States Dollar

NextTrip Inc

Neutra Corp

Northern Trust Corporation - Common Stock

Northern Trust Corp

Northern Trust Corporation - Depositary Shares Each Representing a 1/1,000th Interest in a Share of Series E Non-Cumulative Perpetual Preferred Stock

NATUR INTERNATIONAL CORP by Natur International Corp.

Natur International Corp

US Physical Therapy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USPH#NYSE">USPH</a>) reported quarterly earnings of $0.69 per share which beat the analyst consensus estimate of $0.68 by 1.47 percent. This is a 11.29 percent increase over earnings of $0.62 per share from the same period last year. The company reported quarterly sales of $168.033 million which beat the analyst consensus estimate of $164.381 million by 2.22 percent. This is a 12.02 percent increase over sales of $150.007 million the same period last year.

Earnings

Earnings Beats

USPH

US Physical Therapy Q3 2024 Adj. EPS $0.69 Beats $0.68 Estimate, Sales $168.033M Beat $164.381M Estimate

Guidance

LUMN

Lumen Technologies Continues To Expect FY24 Adjusted EBITDA Of $3.9B - $4.0B, Net Cash Interest Of $1.15B - $1.25B

Gulfport Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPOR#NYSE">GPOR</a>) reported quarterly earnings of $3.42 per share which beat the analyst consensus estimate of $2.93 by 16.72 percent. The company reported quarterly sales of $253.912 million which missed the analyst consensus estimate of $278.980 million by 8.99 percent. This is a 11.73 percent increase over sales of $227.250 million the same period last year.

Earnings Misses

GPOR

Gulfport Energy Q3 2024 Adj. EPS $3.42 Beats $2.93 Estimate, Sales $253.912M Miss $278.980M Estimate

Eos Energy Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EOSE#NASDAQ">EOSE</a>) lowers FY2024 sales outlook from $60.00 million-90.00 million to $15.00 million.

EOSE

Eos Energy Enterprises Lowers FY2024 Sales Guidance from $60.00M-90.00M to $15.00M  VS Est. 62.33M

Macrogenics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGNX#NASDAQ">MGNX</a>) reported quarterly earnings of $0.90 per share which beat the analyst consensus estimate of $0.21 by 328.57 percent. This is a 221.43 percent increase over earnings of $0.28 per share from the same period last year. The company reported quarterly sales of $110.71 million which beat the analyst consensus estimate of $76.11 million by 45.46 percent. This is a 964.81 percent increase over sales of $10.40 million the same period last year.

MGNX

Macrogenics Q3 EPS $0.90 Beats $0.21 Estimate, Sales $110.71M Beat $76.11M Estimate

Forrester Res (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORR#NASDAQ">FORR</a>) reported quarterly earnings of $0.29 per share which missed the analyst consensus estimate of $0.34 by 14.71 percent. This is a 34.09 percent decrease over earnings of $0.44 per share from the same period last year. The company reported quarterly sales of $102.527 million which beat the analyst consensus estimate of $101.944 million by 0.57 percent. This is a 9.61 percent decrease over sales of $113.431 million the same period last year.

FORR

Forrester Res Q3 2024 Adj. EPS $0.29 Misses $0.34 Estimate, Sales $102.527M Beat $101.944M Estimate

B&G Foods Sees FY24 Net Sales $1.920B-$1.950B Vs $1.951B Est.; Adj. Diluted EPS $0.67-$0.77

Cytek Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTKB#NASDAQ">CTKB</a>) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.02) by 150 percent. The company reported quarterly sales of $51.500 million which beat the analyst consensus estimate of $50.696 million by 1.59 percent. This is a 7.29 percent increase over sales of $48.000 million the same period last year.

CTKB

Cytek Biosciences Q3 2024 GAAP EPS $0.01 Beats $(0.02) Estimate, Sales $51.500M Beat $50.696M Estimate

Full year fiscal 2025 guidance:2
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="2" rowspan="1">Current</td>
</tr>
<tr>
<td colspan="1" rowspan="1">GAAP</td>
<td colspan="1" rowspan="1">Low</td>
<td colspan="1" rowspan="1">High</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Revenue</td>
<td colspan="1" rowspan="1">$2,369</td>
<td colspan="1" rowspan="1">$2,391</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Operating margin3</td>
<td colspan="1" rowspan="1">23.0&nbsp;%</td>
<td colspan="1" rowspan="1">23.2&nbsp;%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">EPS</td>
<td colspan="1" rowspan="1">$5.78</td>
<td colspan="1" rowspan="1">$5.87</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Non-GAAP4</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted revenue</td>
<td colspan="1" rowspan="1">$2,353</td>
<td colspan="1" rowspan="1">$2,375</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted operating margin</td>
<td colspan="1" rowspan="1">22.7&nbsp;%</td>
<td colspan="1" rowspan="1">22.8&nbsp;%</td>
</tr>
</tbody>
</table>
</figure>
<a href="https://mma.prnewswire.com/media/2549531/JKHY_Key_Call_Outs___Q1_FY25.html"><img src="https://mma.prnewswire.com/media/2549531/JKHY_Key_Call_Outs___Q1_FY25.jpg" alt="Key Call-Outs" /></a>

JKHY

Jack Henry & Associates Sees FY25 EPS $5.78-$5.87 Vs $5.83 Est.; Revenue $2.353B-$2.375B Vs $2.37B Est.

Latham Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWIM#NASDAQ">SWIM</a>) narrows FY2024 sales outlook from $495.00 million-525.00 million to $500.00 million-510.00 million.

SWIM

Latham Group Narrows FY2024 Sales Guidance from $495.00M-525.00M to $500.00M-510.00M  VS Est. 512.39M

Meme cryptocurrency Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) has experienced a surge in trading volume and price activity leading up to the <a href="https://www.benzinga.com/topic/2024-election">2024 presidential election.</a>
A Benzinga poll asks readers to choose whether a victory by Donald Trump or Kamala Harris in the election could have a more positive impact on Dogecoin in 2025.
What Happened: Dogecoin is up 12% to $0.1761 on Tuesday, with the meme cryptocurrency seeing increased activity likely related to the 2024 election <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41734897/elon-musks-doge-department-mention-gives-dogecoin-boost-to-top-of-daily-gainers-memecoin-s">and positive mentions </a>of the Department of Government Efficiency, or D.O.G.E. for short, by Elon Musk.
Musk is expected to join the Trump administration if the former president wins the 2024 election. In this role, Musk would seek to cut government inefficiencies and unnecessary departments, a role labeled under the D.O.G.E.
The Tesla CEO and billionaire mentioned D.O.G.E. during his<a href="https://www.benzinga.com/general/education/24/11/41752565/if-you-invested-1-000-in-tesla-stock-the-first-time-elon-musk-was-on-the-joe-rogan-podcast-here"> most recent appearance</a> Monday on "The Joe Rogan Experience" podcast, which is likely contributing to Dogecoin's strong movement on Tuesday.
"For Dogecoin's future in 2025, who would be the better president: Kamala Harris or Donald Trump?" Benzinga recently asked.
The results were:
<ul>
<li>Donald Trump: 72%</li>
<li>Kamala Harris: 28%</li>
</ul>
The Benzinga poll found that respondents believe Trump would be more favorable for the future of Dogecoin, which may not come as a surprise given the former president&#8217;s reputation as a more pro-crypto leader.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent110524">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
What's Next: Trump, who previously <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38749745/if-you-invested-1-000-in-bitcoin-when-donald-trump-said-the-cryptos-value-was-based-on-thi">spoke out against Bitcoin, </a>reversed course and has appealed to cryptocurrency investors ahead of the 2024 election.
If Trump wins the 2024 election, cryptocurrency investors expect the price of Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) and other cryptocurrencies to rise with a more crypto-friendly government in place and the likelihood that SEC Chair Gary Gensler will be replaced.
While Harris has not been as vocal on cryptocurrency as Trump, there is belief that she <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41322645/mark-cuban-defends-kamala-harris-crypto-knowledge-appears-to-take-dig-at-trump-for-selling">could look to advance</a> the sector forward if she wins the election.
Either way, Dogecoin could see high volatility during the week as the 2024 election outcome is expected to take some time to make official.
With a price of $0.1761 on Tuesday, Dogecoin is nearing its one-month high of $0.1792.
Over the last 52 weeks, Dogecoin has traded between $0.07028 and $0.2266. Dogecoin hit all-time highs of $0.7376 back in May 2021.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41410605/if-you-invested-100-in-dogecoin-when-elon-musk-first-tweeted-about-the-meme-crypto-heres-h">If You Invested $100 In Dogecoin When Elon Musk First Tweeted About The Meme Crypto, Here&#8217;s How Much You&#8217;d Have Today</a></li>
</ul>
The study was conducted by Benzinga from Nov. 4 through Nov. 5, 2024, and included the responses of a diverse population of adults 18 or older. Opting into the survey was completely voluntary, with no incentives offered to potential respondents. The study reflects results from 134 adults.
Image created with Shutterstock and Midjourney.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Exclusives

$BTC

$DOGE

Dogecoin Jumps On Election Day: Poll Asks If Trump Or Harris Victory Will Spark 2025 Rally

WIIM

Devon Energy shares are trading higher following a Q3 earnings beat.

Ashford Hospitality Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AHT#NYSE">AHT</a>) reported quarterly AFFO of $(1.71) per share which missed the analyst consensus estimate of $(0.97) by 76.29 percent. This is a 311.11 percent decrease over earnings of $0.81 per share from the same period last year. The company reported quarterly sales of $276.60 million which beat the analyst consensus estimate of $268.97 million by 2.84 percent. This is a 19.36 percent decrease over sales of $343.01 million the same period last year.

Ashford Hospitality Trust Q3 2024 AFFO $(1.71) Misses $(0.97) Estimate, Sales $276.60M Beat $268.97M Estimate

Jack Henry &amp; Associates (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JKHY#NASDAQ">JKHY</a>) reported quarterly earnings of $1.63 per share which beat the analyst consensus estimate of $1.61 by 1.24 percent. This is a 17.27 percent increase over earnings of $1.39 per share from the same period last year. The company reported quarterly sales of $600.98 million which beat the analyst consensus estimate of $600.11 million by 0.15 percent. This is a 5.18 percent increase over sales of $571.37 million the same period last year.

Jack Henry & Associates Q1 EPS $1.63 Beats $1.61 Estimate, Sales $600.98M Beat $600.11M Estimate

B&amp;G Foods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BGS#NYSE">BGS</a>) reported quarterly earnings of $0.13 per share which missed the analyst consensus estimate of $0.20 by 35 percent. The company reported quarterly sales of $461.10 million which missed the analyst consensus estimate of $473.12 million by 2.54 percent. This is a 8.28 percent decrease over sales of $502.73 million the same period last year.

B&G Foods Q3 2024 Adj EPS $0.13 Misses $0.20 Estimate, Sales $461.10M Miss $473.12M Estimate

NHI is updating its 2024 annual guidance range which includes the following:
NAREIT FFO per diluted common share to a range of $4.39 - $4.41 from $4.50 - $4.54;
Normalized FFO per diluted common share to a range of $4.43 - $4.44 from $4.52 - $4.56; and
Normalized FAD to a range of $201.8 million - $202.5 million from $200.1 million - $201.8 million;
NAREIT FFO and Normalized FFO revised guidance is primarily due to lower cash lease revenue and interest income assumptions, and a $3.6 million non-cash increase to the credit loss reserve attributable to Senior Living Management. This was partially offset by acquisitions closed since August 2024 funded primarily with forward equity proceeds;
Normalized FAD revised guidance is primarily due to acquisitions closed since August 2024 offset by lower cash lease revenue and interest income assumptions attributable to Senior Living Management.

National Health Investors Updates FY24 NAREIT FFO Per Diluted Share From $4.50-$4.54 To $4.39-$4.41; Normalized FFO Per Diluted Share From $4.52-$4.56 To $4.43-$4.44

Aviat Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVNW#NASDAQ">AVNW</a>) reported quarterly losses of $(0.87) per share which missed the analyst consensus estimate of $(0.03) by 2800 percent. This is a 245 percent decrease over earnings of $0.60 per share from the same period last year. The company reported quarterly sales of $88.43 million which missed the analyst consensus estimate of $94.21 million by 6.14 percent. This is a 1.75 percent increase over sales of $86.91 million the same period last year.

AVNW

Aviat Networks Q1 Adj $(0.87) Misses $(0.03) Estimate, Sales $88.43M Miss $94.21M Estimate

Vtex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTEX#NYSE">VTEX</a>) lowers FY2024 sales outlook from $231.00 million-235.00 million to $230.00 million-232.00 million.

VTEX

Vtex Lowers FY2024 Sales Guidance from $231.00M-235.00M to $230.00M-232.00M.

MASI

Masimo Sees Q4 Revenue $581M-$611M; Q4 Adj. EPS $1.35-$1.50

Vtex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTEX#NYSE">VTEX</a>) sees Q4 sales of $64.800 million-66.800 million vs $67.57 million estimate.

Vtex Sees Q4 Sales $64.800M-66.800M vs $67.57M Est.

The More They Drop, The More I Buy

Analysts have been eager to weigh in on the Materials sector with new ratings on Iperionx Ltd. ADR (IPX – Research Report) and Nutrien (NTR – Resea...

Analysts Have Conflicting Sentiments on These Materials Companies: Iperionx Ltd. ADR (IPX) and Nutrien (NTR)

UBS analyst Joshua Spector downgraded the rating on Nutrien (NTR – Research Report) to a Hold today, setting a price target of $51.00. Joshua Spect...

Hold Rating on Nutrien Amid Soft Agricultural Market and Fair FCF Yield

Nutrien downgraded at UBS on weakening agriculture demand

Analyst Laurence Alexander of Jefferies assigned a Buy rating on Nutrien (NTR – Research Report), with a price target of $62.00. Laurence Alexander...

Strong Pricing Environment and Supply Constraints Bolster Nutrien's Growth Prospects Amid Macroeconomic Challenges

Bullish option flow detected in Nutrien (NTR) with 7,222 calls trading, 9x expected, and implied vol increasing over 1 point to 34.95%. Jan-25 50 c...

Nutrien call volume above normal and directionally bullish

Parnassus Mid Cap Fund Q3 2024 Commentary

Parnassus Mid Cap Growth Fund  Q3 2024 Commentary

In a report released today, Andrew Wong CFA from RBC Capital maintained a Buy rating on Nutrien (NTR – Research Report), with a price target of $60...

Nutrien (NTR): New Buy Recommendation for This Basic Materials Giant

Mosaic, Nutrien surge as Belarus president said to propose cutting potash output

ADSK

BILL

CBRE

CDNS

GWRE

JBHT

KLAC

LPLA

LRCX

MELI

ROST

TEAM

Small Cap

Opinion

Press Releases

Climate-Smart Commodities Program to Benefit 180,000 Farms, Agritech Leads the Way

Nutrien Announces Ken Seitz as a Speaker at the BMO Farm to Market Conference

Future of Food: Agritech Sector's Efforts to Combat Increasing Global Food Security Threats

Nutrien to Highlight Strategic Priorities and 2026 Targets at Investor Day

Nutrien Prices Offering of an Aggregate of US$1.0 Billion of 3-Year and 10-Year Senior Notes

Nutrien Announces Release Dates for Second Quarter 2024 Results and Conference Call

Nutrien Reports Second Quarter 2024 Results and Announces Chief Financial Officer Transition

Nutrien Declares Quarterly Dividend of US$0.54 per Share

Nutrien Announces Release Dates for Third Quarter 2024 Results and Conference Call

BEVVF

CSE:BEE

INGR

TSX:NTR

Wells Fargo

RBC Capital

Goldman Sachs

Barclays

모자이크 컴퍼니(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOS#NYSE">MOS</a>)와 뉴트리엔(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NTR#NYSE">NTR</a>)을 포함한 비료 주식은 벨라루스 대통령 알렉산더 루카셴코가 러시아 생산자들과 함께 칼륨 생산량 감축을 제안한 후 월요일 상승세를 보였다.
알아둘 것 (What To Know): 루카셴코는 러시아 비료 생산자들과 협력하여 칼륨 비료 생산량을 10% 줄여 가격을 인상하자는 제안을 했다. 그는 이 제안을 벨라루스 최대 칼륨 비료 생산업체인 벨라루스칼리(Belaruskali)의 CEO인 안드레이 리바코프(Andrey Rybakov)와의 회의 중에 언급했다. 루카셴코는 감축이 칼륨 가격을 인상시키고 산업이 최근 경제적 압박에 적응하는 데 도움이 될 수 있다고 말했다. 이 내용은 <a href="https://www.bloomberg.com/news/articles/2024-11-04/belarus-president-proposes-cutting-potash-production-with-russia">블룸버그</a>에 의해 보도되었다.
루카셴코는 &#8220;모두가 이 제품이 비싼 제품이며 적절한 가격을 지불해야 한다는 것을 이해할 것이다&#8221;라고 말하며 리바코프에게 이 아이디어를 러시아 기업들과 더 논의해보라고 제안했다.
벨라루스와 러시아는 전 세계 칼륨 비료 공급의 약 40%를 차지하며, 이는 농업 비료의 중요한 성분이다. 벨라루스칼리는 EU와 미국으로부터 제재를 받고 있지만, 러시아의 주요 칼륨 생산업체인 우랄칼리(Uralkali)는 유사한 제재를 받지 않아 시장에서 더 많은 유연성을 가지고 있다.
이 제안된 감축은 다른 시장에서 저렴한 칼륨 공급이 가능하고, 제재와 시장 재편성으로 인해 칼륨 산업이 높은 비용에 직면해 있는 시점에서 나왔다. 만약 시행된다면, 이 협조된 감축은 칼륨 가격을 높이는 데 기여하여 무역 동향 변화 속에서 전 세계 생산자들에게 이익이 될 수 있다.
주가 움직임: 모자이크의 주식은 월요일에 5.36% 상승하여 $28.33에 마감했고, 뉴트리엔의 주식은 5% 상승하여 $50.78에 마감했다.
다음 읽기:
<ul>
<li><a href="https://www.benzinga.com/personal-finance/24/11/41726342/can-you-guess-what-asset-the-ultra-wealthy-invest-in-most-heres-a-hint-its-not-stocks">초고소득자가 가장 많이 투자하는 자산이 무엇인지 맞춰보세요! 힌트: 주식이 아니다.</a></li>
</ul>
이미지 출처: Shutterstock.
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

이들 10개 대형주는 지난 주 최악의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요?
<ol>
<li>셀시어스 홀딩스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELH#NASDAQ">CELH</a>)는 여러 분석가들이 주식 가격 <a href="https://www.benzinga.com/quote/celh/analyst-ratings" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">예측</a>을 낮추면서 지난주 15.22% 하락했다.</li>
<li>골드 필드(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GFI#NYSE">GFI</a>)의 주식은 살라레스 노르테(Salares Norte) 프로젝트에 대한 기상 현상의 <a href="https://www.benzinga.com//node/39317613" target="_blank" rel="noreferrer noopener">영향</a>으로 회사가 2024년 그룹 생산 지침을 낮추면서 12.59% 하락했다.</li>
<li>파라마운트 글로벌(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PARAA#NASDAQ">PARAA</a>)의 주식은 <a class="ticker" href="https://www.benzinga.com/stock/PARAA#NASDAQ">스카이댄스와의 거래가 중단되었다는 소식</a> 이후 13.63% 하락했다.</li>
<li>워너 브라더스 디스커버리(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBD#NASDAQ">WBD</a>)의 주식은 목요일 리버티 글로벌(Liberty Global)이 이 회사의 포뮬러 E <a href="https://www.benzinga.com//node/39318490" target="_blank" rel="noreferrer noopener">지분 인수</a> 의사를 발표한 이후 11.71% 하락했다.</li>
<li>페이팔 홀딩스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>)의 주식은 경쟁사인 어펌(Affirm)의 결제 상품이 올해 말 미국 애플 페이(<a href="https://www.benzinga.com//node/39295963" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">Apple Pay</a>) 사용자들에게 제공될 것이라는 뉴스로 9.16% 하락했다.</li>
<li>삼사라(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IOT#NYSE">IOT</a>)의 주식은 7.66% 하락했다.</li>
<li>오렌지 SA(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORAN#NYSE">ORAN</a>)의 주식은 지난 주 7.66% 떨어졌다.</li>
<li>뉴트리엔(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NTR#NYSE">NTR</a>)의 주식은 파이퍼 샌들러(Piper Sandler)가 비중 축소(Underweight) 평가를 유지하고 <a href="https://www.benzinga.com/quote/ntr/analyst-ratings" target="_blank" rel="noreferrer noopener">주가 목표를 56달러에서 55달러로 낮췄다는 소식</a> 이후 7.14% 떨어졌다.</li>
<li>모빌아이 글로벌(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBLY#NASDAQ">MBLY</a>)의 주식은 7.51% 하락했다.</li>
<li>줌 비디오 커뮤니케이션(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZM#NASDAQ">ZM</a>)의 주식은 7.51% 하락했다.</li>
<li>마이크로스트레티지(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>)의 주식은 회사가 추가 비트코인을 인수하기 위해 한 사모 기관이 5억 달러의 <a href="https://www.benzinga.com//node/39335806" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">전환선순위 채권</a>을 제공하겠다는 제안을 발표한 후 5.88% 하락했다.</li>
</ol>
또한 읽어보기: <a href="https://kr.benzinga.com/news/%ec%95%a0%ed%94%8c%ea%b3%bc-%eb%b8%8c%eb%a1%9c%eb%93%9c%ec%bb%b4%ec%9d%80-%ec%a7%80%eb%82%9c%ec%a3%bc-%ec%b5%9c%ea%b3%a0%ec%9d%98-%ec%84%b1%ea%b3%bc%eb%a5%bc-%eb%b3%b4%ec%9d%b8-10%ea%b0%9c%ec%9d%98/" target="_blank" rel="noopener">애플과 브로드컴은 지난주 최고의 성과를 보인 10개의 대형주 중 일부 (6월 9일-6월 15일)</a>
사진 제공: 셔터스톡

Comments

Nutrien

뉴스

에 대한 최신 뉴스 Nutrien (NYSE:NTR) 주식

월요일, 11월 04, 2024

일요일, 6월 16, 2024

뉴스

파트너 / 기고자

벤징가 글로벌